C-Reactive Protein (CRP) as a Marker in Peripheral Vascular Disease

European Journal of Vascular and Endovascular Surgery

Volumn 34, Issue 1, 2007, Pages 18-22

  Abdellaoui, A ^a   Al Khaffaf, H ^a  

^a BURNLEY GENERAL HOSPITAL   (United Kingdom)

Author keywords

C reactive protein; Intermittent claudication; Peripheral vascular disease

Indexed keywords

C REACTIVE PROTEIN;

ANGIOPLASTY; ANKLE BRACHIAL INDEX; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CLINICAL TRIAL; COCHRANE LIBRARY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE COURSE; DISEASE MARKER; DISEASE SEVERITY; EMBASE; HIGH RISK PATIENT; HUMAN; MEDICAL LITERATURE; MEDLINE; META ANALYSIS; OUTCOME ASSESSMENT; PERIPHERAL VASCULAR DISEASE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; RECURRENCE RISK; REFERENCE VALUE; RESTENOSIS; REVIEW; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW;

BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; DISEASE PROGRESSION; HUMANS; PERIPHERAL VASCULAR DISEASES; PROGNOSIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 34249855043     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1016/j.ejvs.2006.10.040     Document Type: Review

References (31)

1. Khreiss T., József L., Potempa L.A., and Filep J.G. Conformational rearrangement in C-reactive protein is required for proinflammatory actions on human endothelial cells. Circulation 109 (2004) 2016-2022
2. Yeh E.T.H. CRP as a mediator of disease. Circulation 109 Suppl I (2004) II-1-II-14
3. Tracy R.P., Kuller L.H., Psaty B.M., Cushman M., Meilahn E.N., and Smith N. C-reactive protein and incidence of cardiovascular disease in older women: the rural health promotion project and the cardiovascular health study. Circulation 93 (1996) 622
4. Liuzzo G., Biasucci L.M., Gallimore J.R., Grillo R.L., Rebuzzi A.G., Pepys M.B., et al. The prognostic value of C-reactive protein and serum amyloid. A protein in severe unstable angina. N Engl J Med 331 (1994) 417-424
5. Ledue T.B., and Rifai N. Preanalytic and analytic sources of variations in C-reactive protein measurement: implications for cardiovascular disease risk assessment. Clin Chem 49 (2003) 1258-1271
6. Ford E.S., Giles W.H., Mokdad A.H., and Myers G.L. Distribution and correlates of C-reactive protein concentrations among adult US women. Clin Chem 50 3 (2004) 574-581
7. Roivainen M., Viik-Kajander M., Palosuo T., Toivanen P., Leinonen M., Saikku P., et al. Infections, inflammation, and the risk of coronary heart disease. Circulation 101 (2000) 252-257
8. Pearson T.A., Mensah G.A., Alexander W.R., Anderson J.L., Cannon R.O., Criqui M., et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107 (2003) 499-511
9. Rifai N., and Ridker P.M. High-sensitivity C-reactive protein: a novel and promising marker of coronary heart disease. Clin Chem 47 (2001) 403-411
10. Morrow D.A., and Ridker P.M. High sensitivity C-reactive protein (hs-CRP): a novel risk marker in cardiovascular disease. Prev Cardiol 1 (1999) 13-1641
11. Danesh J., Whincup P., Walker M., Lennon L., Thomson A., Appleby P., et al. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ 321 (2000) 199-204
12. Ridker P.M., Hennekens C.H., Buring J.E., and Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342 (2000) 836-843
13. Ridker P.M., Cushman M., Stampfer M.J., Tracy R.P., and Hennekens C.H. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336 (1997) 973-979
14. Koenig W., Sund M., Frohlich M., Fischer H.G., Lowel H., Doring A., et al. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation 99 (1999) 237-242
15. Rost N.S., Wolf P.A., Kase C.S., Kelly-Hayes M., Silbershatz H., Massaro J.M., et al. Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study. Stroke 32 (2001) 2575-2579
16. Albert C.M., Ma J., Rifai N., Stampfer M.J., and Ridker P.M. Prospective study of C-reactive protein, homocysteine, and plasma lipid levels as predictors of sudden cardiac death. Circulation 105 (2002) 2595-2599
17. Ridker P.M., Stampfer M.J., and Rifai N. Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA 285 (2001) 2481-2485
18. Ridker P.M., Cushman M., Stampfer M.J., Tracy R.P., and Hennekens C.H. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation 97 (1998) 425-428
19. Tzoulaki I., Murray G.D., Lee A.J., Rumley A., Lowe G.D.O., and Fowkes F.G.R. C-reactive protein, Interleukin-6, and soluble adhesion molecules as predictors of progressive peripheral atherosclerosis in the general population: Edinburgh artery study. Circulation 112 (2005) 976-983
20. Van Der Meer I.M., De Maat M.P., Hak A.E., Kiliaan A.J., Del Sol A.I., Van Der Kuip D.A., et al. C-reactive protein predicts progression of Atherosclerosis measured at various sites in the arterial tree: the Rotterdam study. Stroke 33 (2002) 2750-2755
21. Bloemenkamp D.G., Van Den Bosch M.A., Mali W.P., Tanis B.C., Rosendaal F.R., Kemmeren J.M., et al. Novel risk factors for peripheral arterial disease in young women. Am J Med 113 6 (2002) 462-467
22. Cassar K., Ford I., Greaves M., Bachoo P., and Brittenden J. Randomized clinical trial of the antiplatelet effects of aspirin-clopidogrel combination versus aspirin alone after lower limb angioplasty. Br J Surg 92 2 (2005 Feb) 159-165
23. Vu J.D., Vu J.B., Pio J.R., Malik S., Franklin S.S., Chen R.S., et al. Impact of C-reactive protein on the likelihood of peripheral arterial disease in United States adults with the metabolic syndrome, Diabetes Mellitus, and pre-existing cardiovascular disease. Am J Cardiol 96 5 (2005) 655-658
24. McDermott M.M., Green D., Greenland P., Liu K., Criqui M.H., Chan C., et al. Relation of levels of hemostatic factors and inflammatory markers to the ankle brachial index. Am J Cardiol 92 (2003) 194-199
25. McDermott M.M., Greenland P., Guralnik J.M., Ferrucci L., Green D., Liu K., et al. Inflammatory markers, D-dimer, pro-thrombotic factors, and physical activity levels in patients with peripheral arterial disease. Vasc Med 9 2 (2004) 107-115
26. Vainas T., Stassen F., de Graaf R., Twiss E., Herngreen S., Welten R., et al. C-reactive protein in peripheral arterial disease: relation to severity of the disease and to future cardiovascular events. J Vasc Surg 42 2 (2005) 243-251
27. Hozawa A., Ohmori K., Kuriyama S., Shimazu T., Niu K., Watando A., et al. C-reactive protein and peripheral artery disease among Japanese elderly: the Tsurugaya Project. Hypertens Res 27 12 (2004) 955-961
28. Aboyans V., Criqui M.H., Denenberg J.O., Knoke J.D., Ridker P.M., and Fronek A. Risk factors for progression of peripheral arterial disease in large and small vessels. Circulation 113 22 (2006 Jun 6) 2623-2629
29. Musicant S.E., Taylor Jr. L.M., Peters D., Schuff R.A., Urankar R., Landry G.J., et al. Prospective evaluation of the relationship between C-reactive protein, D-dimer and progression of peripheral arterial disease. J Vasc Surg 43 4 (2006 Apr) 772-780 (discussion 780)
30. Schillinger M., Exner M., Mlekusch W., Haumer M., Rumpold H., Ahmadi R., et al. Endovascular revascularization below the knee: 6-month results and predictive value of C-reactive protein level. Radiology 227 (2003) 419-425
31. Schillinger M., Exner M., Mlekusch W., Rumpold H., Ahmadi R., Sabeti S., et al. Vascular inflammation and percutaneous transluminal angioplasty of the femoropopliteal artery: association with Restenosis. Radiology 225 (2002) 21-26